Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Barrett

Showing results (161-170 of 167) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 167 results.
Nature Genetics|September 2, 2020
Chromatin binding of FOXA1 is promoted by LSD1-mediated demethylation in prostate cancerShuai Gao, Sujun Chen, Dong Han, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2025
D3-GPC2-Directed CAR T Cells Are Safe and Efficacious in Preclinical Models of Neuroblastoma and Small Cell Lung CancerAnna Maria Giudice, Stephanie Matlaga, Sydney L Roth, et al.
Nature Medicine|March 14, 2024
Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim resultsStephen J Bagley, Meghan Logun, Joseph A Fraietta, et al.
Nature Medicine|June 1, 2025
Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trialStephen J Bagley, Arati S Desai, Joseph A Fraietta, et al.
Archives of Sexual Behavior|March 17, 2026
How Do People Maintain Consensual Non-Monogamy? An International Development and Validation of the Multiple Relationships Maintenance ScaleJustin K Mogilski, Geoffrey F Miller, Peter K Jonason, et al.
Nature Medicine|June 11, 2025
Author Correction: Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trialStephen J Bagley, Arati S Desai, Joseph A Fraietta, et al.
Cell|June 15, 2026
The critical role of the endogenous immune compartment after CAR T cell therapy in recurrent GBMNelson F Freeburg, Daniel Chafamo, Gayathri Konanur Gopikrishna, et al.
Pageof 17

Showing results (161-170 of 167) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 167 results.
Nature Genetics|September 2, 2020
Chromatin binding of FOXA1 is promoted by LSD1-mediated demethylation in prostate cancerShuai Gao, Sujun Chen, Dong Han, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2025
D3-GPC2-Directed CAR T Cells Are Safe and Efficacious in Preclinical Models of Neuroblastoma and Small Cell Lung CancerAnna Maria Giudice, Stephanie Matlaga, Sydney L Roth, et al.
Nature Medicine|March 14, 2024
Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim resultsStephen J Bagley, Meghan Logun, Joseph A Fraietta, et al.
Nature Medicine|June 1, 2025
Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trialStephen J Bagley, Arati S Desai, Joseph A Fraietta, et al.
Archives of Sexual Behavior|March 17, 2026
How Do People Maintain Consensual Non-Monogamy? An International Development and Validation of the Multiple Relationships Maintenance ScaleJustin K Mogilski, Geoffrey F Miller, Peter K Jonason, et al.
Nature Medicine|June 11, 2025
Author Correction: Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trialStephen J Bagley, Arati S Desai, Joseph A Fraietta, et al.
Cell|June 15, 2026
The critical role of the endogenous immune compartment after CAR T cell therapy in recurrent GBMNelson F Freeburg, Daniel Chafamo, Gayathri Konanur Gopikrishna, et al.
Pageof 17